Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Bruker (BRKR) over the last 17 years, with Q3 2025 value amounting to $4.0 billion.

  • Bruker's Total Liabilities fell 666.07% to $4.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year decrease of 666.07%. This contributed to the annual value of $4.0 billion for FY2024, which is 4071.42% up from last year.
  • According to the latest figures from Q3 2025, Bruker's Total Liabilities is $4.0 billion, which was down 666.07% from $4.5 billion recorded in Q2 2025.
  • Bruker's Total Liabilities' 5-year high stood at $4.5 billion during Q2 2025, with a 5-year trough of $2.0 billion in Q3 2021.
  • In the last 5 years, Bruker's Total Liabilities had a median value of $2.6 billion in 2023 and averaged $3.0 billion.
  • Per our database at Business Quant, Bruker's Total Liabilities skyrocketed by 6469.82% in 2024 and then tumbled by 666.07% in 2025.
  • Quarter analysis of 5 years shows Bruker's Total Liabilities stood at $2.6 billion in 2021, then fell by 3.33% to $2.5 billion in 2022, then increased by 14.38% to $2.8 billion in 2023, then surged by 40.71% to $4.0 billion in 2024, then dropped by 0.15% to $4.0 billion in 2025.
  • Its Total Liabilities stands at $4.0 billion for Q3 2025, versus $4.5 billion for Q2 2025 and $4.1 billion for Q1 2025.